317 related articles for article (PubMed ID: 19376075)
1. Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.
Sotty F; Folgering JH; Brennum LT; Hogg S; Mørk A; Hertel P; Cremers TI
Neuropharmacology; 2009 Jul; 57(1):18-24. PubMed ID: 19376075
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism.
Boothman L; Raley J; Denk F; Hirani E; Sharp T
Br J Pharmacol; 2006 Dec; 149(7):861-9. PubMed ID: 17043669
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.
Cremers TI; Rea K; Bosker FJ; Wikström HV; Hogg S; Mørk A; Westerink BH
Neuropsychopharmacology; 2007 Jul; 32(7):1550-7. PubMed ID: 17203017
[TBL] [Abstract][Full Text] [Related]
4. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.
Dremencov E; El Mansari M; Blier P
J Psychiatry Neurosci; 2009 May; 34(3):223-9. PubMed ID: 19448853
[TBL] [Abstract][Full Text] [Related]
5. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.
Arborelius L; Wallsten C; Ahlenius S; Svensson TH
Eur J Pharmacol; 1999 Oct; 382(2):133-8. PubMed ID: 10528148
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade.
Cremers TI; Giorgetti M; Bosker FJ; Hogg S; Arnt J; Mørk A; Honig G; Bøgesø KP; Westerink BH; den Boer H; Wikstrom HV; Tecott LH
Neuropsychopharmacology; 2004 Oct; 29(10):1782-9. PubMed ID: 15138437
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; De Montigny C; Blier P
Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
Boothman LJ; Mitchell SN; Sharp T
Neuropharmacology; 2006 May; 50(6):726-32. PubMed ID: 16434063
[TBL] [Abstract][Full Text] [Related]
12. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
13. Lack of CB1 receptor activity impairs serotonergic negative feedback.
Aso E; Renoir T; Mengod G; Ledent C; Hamon M; Maldonado R; Lanfumey L; Valverde O
J Neurochem; 2009 May; 109(3):935-44. PubMed ID: 19302195
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
Hughes ZA; Starr KR; Scott CM; Newson MJ; Sharp T; Watson JM; Hagan JJ; Dawson LA
Psychopharmacology (Berl); 2007 May; 192(1):121-33. PubMed ID: 17265079
[TBL] [Abstract][Full Text] [Related]
16. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
[TBL] [Abstract][Full Text] [Related]
17. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.
Bosker FJ; Folgering JH; Gladkevich AV; Schmidt A; van der Hart MC; Sprouse J; den Boer JA; Westerink BH; Cremers TI
J Neurochem; 2009 Mar; 108(5):1126-35. PubMed ID: 19166502
[TBL] [Abstract][Full Text] [Related]
19. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
20. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
